Hi Mozz, I had a listen to this last night. It’s fascinating to go back and listen to the conviction and excitement Paul has. One question I have, the phase 2b 008 study was inserted into the program post this cap raising. It’s clearly got Doc Virginia Kraus consulting work all over it one would wonder. Do you know what date she joined the team?
It’s now got me thinking, our OA deals will start falling early 2024, once the MPS asset has its deal completed in some regions and the per course treatment for MPS patients is finalised by a jurisdiction.
Par has this all wrapped up quite nicely at the minute.
Hi Mozz, I had a listen to this last night. It’s fascinating to...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.010(4.00%) |
Mkt cap ! $91.06M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $36.40K | 143.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40816 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 44646 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |